Partner news
News
Partner news
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
Read full storyPartner news
Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen
Read full storyPartner news
£10 million research collaboration to detect lung cancer earlier
Read full storyPartner news
Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform
Read full storyPartner news
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
Read full storyPartner news
MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® Molecule
Read full storyPartner news
Australian National University Announces Research Project with Janssen to Help Develop New Methods for Measuring and Monitoring Type 1 Diabetes
Read full storyPartner news
Symvivo Corporation Announces Research Agreement with Janssen to Offer Novel Approach to Therapeutic Protein Delivery
Read full storyPartner news
CHO Plus Announces Research Collaboration Agreement with Janssen to Improve Manufacturing of Therapeutic Proteins
Read full storyPartner news
UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease
Read full storyPartner news
Xencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate Cancer
Read full storyPartner news
Janssen Acquires Rights to Novel Gene Therapy, Pioneering Treatment Solutions for Late-Stage Age-Related Macular Degeneration
Read full storyPartner news
Koa Health to collaborate with Janssen: Official press release
Read full storyPartner news